[RGLS] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
13-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -1.65%
YoY- -182.72%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 1,631 5,454 6,118 4,759 3,238 3,238 2,809 -30.42%
PBT -12,740 -1,946 -2,169 -7,338 -7,239 -6,858 -5,691 71.21%
Tax 1 -19 -5 10 -10 18 -6 -
NP -12,741 -1,927 -2,164 -7,348 -7,229 -6,876 -5,685 71.34%
Tax Rate - - - - - - - -
Total Cost 14,372 7,381 8,282 12,107 10,467 10,114 8,494 42.03%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -781.18 -35.33 -35.37 -154.40 -223.26 -212.35 -202.39 146.26%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -35.81 -5.53 -6.47 -24.50 -24.18 -23.03 -1,918.02 -92.97%
EPS Diluted -35.81 -5.35 -6.25 -24.50 -24.18 -23.00 -1,918.02 -92.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.